Photocure ASA is a Norwegian pharmaceutical company listed on Oslo Stock Exchange (PHO). The company develops and sells innovative solutions based on photodynamic technology, targeting key dermatology and cancer markets.
Photocure has one product with sales and marketing approvals:
- Hexvix®, for the detection of bladder cancer.
The product is based on the Photocure Technology, which combine a drug with a source of light to achieve its effects and results. Photocure is currently developing a pipeline of follow-on products and technologies.